1. Home
  2. MRKR vs DSY Comparison

MRKR vs DSY Comparison

Compare MRKR & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

N/A

Current Price

$1.00

Market Cap

19.5M

Sector

Health Care

ML Signal

N/A

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

N/A

Current Price

$3.18

Market Cap

15.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MRKR
DSY
Founded
1999
2020
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
15.7M
IPO Year
2010
2023

Fundamental Metrics

Financial Performance
Metric
MRKR
DSY
Price
$1.00
$3.18
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $7.87
N/A
AVG Volume (30 Days)
★ 168.4K
4.6K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 33.61
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$19.61
N/A
Revenue Next Year
$375.85
N/A
P/E Ratio
★ N/A
$16.48
Revenue Growth
N/A
★ N/A
52 Week Low
$0.84
$0.17
52 Week High
$2.46
$19.90

Technical Indicators

Market Signals
Indicator
MRKR
DSY
Relative Strength Index (RSI) 45.81 40.66
Support Level $0.88 $2.80
Resistance Level $1.32 $3.62
Average True Range (ATR) 0.12 0.15
MACD 0.00 0.01
Stochastic Oscillator 31.33 2.22

Price Performance

Historical Comparison
MRKR
DSY

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

Share on Social Networks: